Skip to content
OpenCapital
Get started

GoodRx Holdings, Inc. GDRX Selling Expense

Selling Expense at other companies

RVL
Revolve GroupRVLV
$57.7M+15.5%
Balchem logo
BalchemBCPC
$21.1M+24.6%
United Airlines Holdings logo
United Airlines HoldingsUAL
$522M+5.2%
Abercrombie & Fitch logo
Abercrombie & FitchANF
$431.2M+7.8%
Teladoc Health logo
Teladoc HealthTDOC
$51.28M+5.3%
Matthews International logo
Matthews InternationalMATW
$26.13M-29.3%

Segments

By product

See full
Prescription transactions revenue$11.2M-2.6%

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$934.74M-44.5%
Enterprise value$1.24B-35.4%
P/E45.5×-13.8×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×